ADHD Medication Pregnancy: The Good, The Bad, And The Ugly > 자유게시판

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medication during pregnancy and nursing is a challenge for women suffering from the condition. There aren't enough data regarding how exposure over time may affect the foetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus do not develop neurological developmental disorders like impaired vision or hearing seizures, febrile seizures or IQ impairment. The authors acknowledge that more high quality studies are needed.

Risk/Benefit Analysis

Pregnant women who take ADHD medications need to balance the advantages of taking them against potential risks to the foetus. Doctors don't have the data needed to give clear guidelines but they can provide information about the risks and benefits to aid pregnant women in making informed choices.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during early pregnancy were not at greater risk of fetal malformations or structural birth defects. Researchers conducted a massive sample-based case control study to assess the frequency of major structural defects in infants born to mothers who used stimulants during pregnancy. Pediatric cardiologists, clinical geneticists and other experts examined the cases to make sure that the classification was correct and to reduce any bias.

However, the study was not without its flaws. The researchers were unable to, in the first place, to separate the effects caused by the medication from the disorder. This limitation makes it difficult for researchers to determine whether the few associations observed between the groups that were exposed to medication use, or if they were caused by co-morbidities. In addition the study did not examine the long-term effects of offspring on their parents.

The study did reveal that infants whose mothers had taken best adhd medication for adults medication during pregnancy were at a slightly more risk of being admitted to the neonatal intensive care unit (NICU) than infants who were born without any medication or had cut back on their medications prior to or during pregnancy. This was due to central nervous system-related disorders, and the increased risk of admission was not found to be influenced by the stimulant medications were taken during pregnancy.

Women who were taking stimulant ADHD medication during pregnancy were also at an increased chance of having a caesarean section or having a child with low Apgar score (less than 7). These increases didn't appear to be influenced by the kind of medication used during pregnancy.

The researchers suggest that the low risk associated with the use of ADHD medications during early pregnancy may be offset by the greater benefit to both the mother and child from continued treatment for the woman's condition. Physicians should speak with their patients about this issue and try to help them develop coping strategies that may reduce the impact of her disorder in her daily functioning and [empty] her relationships.

Interactions with Medication

Many doctors are faced with the decision of whether to maintain treatment or stop during pregnancy as more women are diagnosed with ADHD. These decisions are frequently made without clear and reliable evidence. Instead, physicians must consider their own expertise in conjunction with the experiences of other doctors and the research that has been conducted on the subject.

The issue of possible risks for infants can be difficult to determine. Many of the studies on this topic are based on observational data instead of controlled research and their conclusions are often contradictory. Furthermore, most studies restrict their analysis to live births, which could underestimate the severity of teratogenic effects that could cause abortion or termination of the pregnancy. The study discussed in this journal club addresses these issues by looking at data from both live and deceased births.

Conclusion: While some studies have shown an association between ADHD medications and certain birth defects, other studies have not shown such a relationship. Most studies show an unintended, or slight negative effect. In each case an in-depth analysis of the benefits and risks must be performed.

For a lot of women with ADHD who suffer from ADHD, the decision to discontinue medication is difficult, if not impossible. In a recent article published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of being isolated. Furthermore, a loss of medication may affect the ability to complete jobs and drive safely, which are important aspects of a normal life for many people suffering from ADHD.

She suggests that women who are unsure whether to continue taking medication or stop it due to their pregnancy, educate their family members, colleagues, and acquaintances about the condition, the impact on daily functioning and the benefits of keeping the current treatment regimen. It can also aid in ensuring that the woman feels supported as she struggles with her decision. It is also worth noting that certain medications can pass through the placenta, so if the patient decides to stop taking her adhd medication for women medication during pregnancy and breastfeeding, she should be aware of the possibility that traces of the medication could be transferred to the infant.

Birth Defects and Risk of

As the use and use of ADHD medications to treat the symptoms of attention deficit hyperactivity disorder (ADHD) increases the concern over the potential adverse effects of the drugs on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this subject. With two massive data sets researchers were able examine more than 4.3 million pregnancies to determine whether the use of stimulant medications increased the risk of birth defects. Researchers found that while the overall risk is low, first-trimester common adhd medications uk medication use was associated with slightly higher risk of specific heart defects such as ventriculoseptal defect.

The researchers of the study could not discover any link between the use of early medications and other congenital anomalies such as facial deformities or club feet. The results are in line with previous studies showing an increase, but not significant, in the risk of developing cardiac malformations among women who started taking ADHD medications prior to the time of the birth of their child. This risk increased during the latter half of pregnancy when a large number of women decided to stop taking their medication.

Women who took Adhd medication without diagnosis uk medications during the first trimester of pregnancy were also more likely to experience a caesarean section, a low Apgar score after delivery and a baby who needed breathing assistance during birth. However the authors of the study were not able to eliminate selection bias by limiting the study to women who didn't have other medical issues that could be a contributing factor to these findings.

Researchers hope that their research will help doctors when they meet pregnant women. The researchers suggest that while discussing the risks and benefits are important, the choice regarding whether or not to stop medication should be in light of the severity of each woman's ADHD symptoms and her requirements.

The authors also advise that, while stopping the medication is an option, it isn't a recommended practice because of the high rate of depression and other mental health issues for women who are expecting or recently postpartum. Furthermore, research suggests that women who choose to stop taking their medications are more likely to have a difficult time getting used to life without them following the birth of their baby.

Nursing

It can be a stressful experience to become a mom. Women who suffer from ADHD who must work through their symptoms while attending doctor appointments, preparing for the arrival of a baby and adjusting to new household routines can experience severe challenges. As such, many women elect to continue taking their ADHD medications throughout pregnancy.

The majority of stimulant medicines are absorbed by breast milk in low amounts, therefore the risk for breastfeeding infant is minimal. However, the amount of exposure to medication by the infant can differ based on dosage, how often it is administered, and at what time the medication is administered. Additionally, different medications enter the body of the baby differently through the gastrointestinal tract and breast milk. The impact of this on a newborn is not fully understood.

Due to the absence of research, some physicians might be tempted to stop taking stimulant medications during the pregnancy of a woman. This is a complicated decision for the patient, who must weigh the benefits of keeping her medication with the potential dangers to the embryo. In the meantime, until more information is available, doctors can ask pregnant patients whether they have any background of ADHD or if they intend to take medication in the perinatal phase.

Numerous studies have proven that women can continue to take their ADHD medication in a safe manner during pregnancy and while breast-feeding. In the end, many patients are choosing to do so and, in consultation with their physician, they have found that the benefits of continuing their current medication outweigh any risks.

Women who suffer from ADHD who plan to breastfeed should seek the advice of a specialist psychiatrist before becoming pregnant. They should discuss their medication with their prescriber, and the pros and cons of continuing treatment. This includes non-pharmacological strategies. Psychoeducation is also required to help women with ADHD understand their symptoms and underlying disorder and learn about treatment options and strengthen existing coping strategies. This should be a multidisciplinary effort together with obstetricians, GPs, and psychiatrists. Pregnancy counseling should include discussion of a treatment plan for the mother and the child, monitoring of signs of deterioration, and, if necessary, adjustments to the medication regime.